Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
1
33%
Ph phase_4
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingearly_phase_1

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

NCT06611111
completedphase_4

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

NCT07013812
unknownnot_applicable

Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose

NCT02331069

Clinical Trials (3)

Showing 3 of 3 trials
NCT06611111Early Phase 1

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

Recruiting
NCT07013812Phase 4

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

Completed
NCT02331069Not Applicable

Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3